Valuation — not yet established
No valuation for AZTherapies is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($71.1M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 8 rounds
- ·Watchlist + deal alerts for AZTherapies
Create free account
No card required
Funding history
8 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2020 | Later Stage VC (Series C1) | $33.6M | ▮ | ▮ |
| Jan 2020 | Later Stage VC (Series C) | $37.5M | ▮ | ▮ |
| May 2019 | Early Stage VC | $5.6M | ▮ | ▮ |
| Jun 2018 | Early Stage VC | $16.1M | ▮ | ▮ |
| Dec 2017 | Seed Round | $1.6M | ▮ | ▮ |
| Jun 2017 | Early Stage VC | $6.5M | ▮ | ▮ |
| + 2 earlier rounds · a free account shows the full history | ||||
How AZTherapies's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For AZTherapies, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has AZTherapies raised?
- AZTherapies has raised $71.1M in total funding across 8 recorded rounds.
- When did AZTherapies last raise?
- AZTherapies last raised in Sep 2020 (Later Stage VC (Series C1)), raising $33.6M.